Skip to main content

Table 1 Correlation between STIL mRNA level and clinical characteristics in BLCA patients

From: STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer

 

STIL expression

High expression

Low expression

Total

χ2

P-value

Gender

 Female

22 (26.8%)

8 (9.6%)

30 (18.2%)

7.0794

0.007798

 Male

60 (73.2%)

75 (90.4%)

135 (81.8%)

  

Age

 < 60

17 (20.7%)

29 (34.9%)

46 (27.9%)

3.4648

0.06269

 ≥ 60

65 (79.3%)

54 (65.1%)

119 (72.1%)

  

Pathologic T

 Ta

5 (6.1%)

19 (22.9%)

24 (14.5%)

18.409

0.001026

 T1

36 (43.9%)

44 (53.0%)

80 (48.5%)

  

 T2

18 (22.0%)

13 (15.7%)

31 (18.8%)

  

 T3

15 (18.3%)

4 (4.8%)

19 (11.5%)

  

 T4

8 (9.8%)

3 (3.6%)

11 (6.7%)

  

Pathologic N

 N0

69 (84.1%)

80 (96.4%)

149 (90.3%)

5.7278

0.0167

 N1-3/Nx

13 (15.9%)

3 (3.6%)

16 (9.7%)

  

Pathologic M

 M0

78 (95.1%)

80 (96.4%)

158 (95.8%)

0.00027

0.9869

 M1

4 (4.9%)

3 (3.6%)

7 (4.2%)

  

Grade

 High grade

48 (58.5%)

12 (14.5%)

60 (36.4%)

32.755

1.046e-08

 Low grade

34 (41.5%)

71 (85.5%)

105 (63.6%)

  

Invasiveness

 No

40 (48.8%)

63 (75.9%)

103 (62.4%)

11.806

0.0005903

 Yes

42 (51.2%)

20 (24.1%)

62 (37.6%)

 Â